Chapin Davis’s Astera Labs ALAB Stock Holding History

Chapin Davis’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.53M	Hold	11,451	–	–	0.97%	28
2026 Q1	$1.26M	Hold	11,451	–	–	0.28%	75
2025 Q4	$1.9M	Hold	11,451	–	–	0.45%	49
2025 Q3	$2.24M	Hold	11,451	–	–	0.55%	41
2025 Q2	$1.04M	Buy	+11,451	New	+$905K	0.29%	77

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chapin Davis's ALAB Position: Q2 2026 in Review

Chapin Davis held its Astera Labs (ALAB) position steady in Q2 2026 at 11,451 shares worth $5.53M. The position accounts for 0.97% of the portfolio, ranked #28.

Chapin Davis first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Chapin Davis held 11,451 shares of Astera Labs worth $5.53M as of Q2 2026.
Chapin Davis left its Astera Labs share count unchanged in Q2 2026.
Astera Labs made up 0.97% of Chapin Davis's portfolio in Q2 2026, its #28 holding.
Chapin Davis first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Chapin Davis's 13F filing for Q2 2026, filed 7 Jul 2026.